作者: Vladimira Tichà , Elena Repetti , Tshering Dorji , Bruno Damascelli
DOI: 10.1016/J.JVIR.2021.02.010
关键词:
摘要: Abstract Liquid biopsy is a molecular diagnostic procedure that aims to provide readily accessible genetic profiling of tumors for primary diagnosis, detection minimal residual or metastatic disease, and therapeutic decision-making, especially molecularly targeted treatments. Cancers release various biological markers into the circulation, although most widely used are cell-free tumor DNA circulating cells. The paucity material means laboratory methods mainly based on sequencing expose this innovative method considerable incidence false negatives. 3 cases presented here show how sensitivity specificity liquid may be improved through selective venous sampling.